Ποια είναι η τιμή για Procyon Corporation (PCYN)

Η τιμή για Procyon Corporation (PCYN) είναι $0.28

Ποια είναι η κεφαλαιοποίηση αγοράς για Procyon Corporation (PCYN)

Η κεφαλαιοποίηση αγοράς για Procyon Corporation (PCYN) είναι $2.27M

Procyon Corporation (PCYN) Τιμή και Κεφαλαιοποίηση Αγοράς

Procyon Corporation, along with its affiliated entities, specializes in the development and distribution of proprietary medical solutions. Their primary focus is on addressing various skin conditions, including pressure and stasis ulcers, general wounds, dermatitis, inflammation, and other dermatological issues, predominantly within the United States. The company offers a diverse array of products. Under the AMERIGEL brand, they provide sophisticated skin and wound healing items such as hydrogel dressings, post-operative surgical kits, saline wound rinses, and protective lotions, in addition to hand sanitizer. Their HELIX3 line features Bioactive Collagen products, available in both powder and matrix forms. For comprehensive wound management, the AMERX brand includes various dressing types like calcium alginate, foam, gauze, and hydrocolloid, as well as complete wound care kits containing components like collagen matrix, collagen powder, foam, and hydrogel. Furthermore, Procyon markets compression garments under the EXTREMIT-EASE name. These offerings are distributed through multiple channels: to institutional clients such as hospitals, wound care clinics, nursing homes, home health agencies, and medical practitioners via distributors, and directly to individual consumers through online sales, direct purchases, and independent or chain pharmacies. Founded in 1987, the company's operations are headquartered in Clearwater, Florida.

Η τιμή για PCYN	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$671,355 $2.27M	NVDA	$5.452T	+239,769,495.49%
$552,911 $2.27M	AAPL	$4.490T	+197,468,065.47%
$512,568 $2.27M	GOOG	$4.162T	+183,059,852.28%
$452,713 $2.27M	MSFT	$3.676T	+161,683,048.35%
$348,867 $2.27M	AMZN	$2.833T	+124,595,271.27%

Η τιμή για PCYN

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$671,355 $2.27M